Androgen deprivation therapy for prostate cancer: indications, contraindications and possible consequences

Androgen deprivation therapy (ADT) has been the mainstay of palliative treatment in advanced and metastatic prostate cancer for many years. It is also increasingly being used in patients with localized disease. Here we review some recent trials that are providing information on its benefits and disa...

Descripción completa

Detalles Bibliográficos
Autores principales: Karl, Alexander, Konety, Badrinath
Formato: Texto
Lenguaje:English
Publicado: Medicine Reports Ltd 2009
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920692/
https://www.ncbi.nlm.nih.gov/pubmed/20948762
http://dx.doi.org/10.3410/M1-2
_version_ 1782185301539553280
author Karl, Alexander
Konety, Badrinath
author_facet Karl, Alexander
Konety, Badrinath
author_sort Karl, Alexander
collection PubMed
description Androgen deprivation therapy (ADT) has been the mainstay of palliative treatment in advanced and metastatic prostate cancer for many years. It is also increasingly being used in patients with localized disease. Here we review some recent trials that are providing information on its benefits and disadvantages in different circumstances.
format Text
id pubmed-2920692
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Medicine Reports Ltd
record_format MEDLINE/PubMed
spelling pubmed-29206922010-10-14 Androgen deprivation therapy for prostate cancer: indications, contraindications and possible consequences Karl, Alexander Konety, Badrinath F1000 Med Rep Review Article Androgen deprivation therapy (ADT) has been the mainstay of palliative treatment in advanced and metastatic prostate cancer for many years. It is also increasingly being used in patients with localized disease. Here we review some recent trials that are providing information on its benefits and disadvantages in different circumstances. Medicine Reports Ltd 2009-01-21 /pmc/articles/PMC2920692/ /pubmed/20948762 http://dx.doi.org/10.3410/M1-2 Text en © 2009 Medicine Reports Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use this work for commercial purposes
spellingShingle Review Article
Karl, Alexander
Konety, Badrinath
Androgen deprivation therapy for prostate cancer: indications, contraindications and possible consequences
title Androgen deprivation therapy for prostate cancer: indications, contraindications and possible consequences
title_full Androgen deprivation therapy for prostate cancer: indications, contraindications and possible consequences
title_fullStr Androgen deprivation therapy for prostate cancer: indications, contraindications and possible consequences
title_full_unstemmed Androgen deprivation therapy for prostate cancer: indications, contraindications and possible consequences
title_short Androgen deprivation therapy for prostate cancer: indications, contraindications and possible consequences
title_sort androgen deprivation therapy for prostate cancer: indications, contraindications and possible consequences
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920692/
https://www.ncbi.nlm.nih.gov/pubmed/20948762
http://dx.doi.org/10.3410/M1-2
work_keys_str_mv AT karlalexander androgendeprivationtherapyforprostatecancerindicationscontraindicationsandpossibleconsequences
AT konetybadrinath androgendeprivationtherapyforprostatecancerindicationscontraindicationsandpossibleconsequences

Ejemplares similares